AstraZeneca Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test The firms will develop the NGS-based CDx for non-small cell lung cancer drug Tagrisso using the Oncomine Dx Express Test on the Genexus Dx System. AstraZeneca to Evaluate C2i Genomics' Cancer Detection, Monitoring Platform AstraZeneca will assess the startup's test on patient-derived samples, following a previous collaboration that used artificially generated samples. Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer This clinical study, called Sculptor, is the first research to emerge from a strategic collaboration between the companies on oncology therapeutics. Guardant Health, AstraZeneca Partner on Liquid Biopsy CDx for Breast Cancer Drug The companies forged a multi-year partnership in 2018 to develop blood-based companion diagnostic tests for drugs in AstraZeneca's oncology portfolio. Exome Sequencing Study Identifies Potential Treatment Target for Diabetes Individuals with protein-truncating MAP3K15 variants are less likely to develop diabetes, suggesting it could also be a possible target for managing the disease. Oct 27, 2022 Invitae, AstraZeneca Partner for Cholangiocarcinoma Study Using Ciitizen Data Platform Oct 11, 2022 Illumina, AstraZeneca Partner on AI-Based Drug Target Discovery Sep 11, 2022 Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients Premium Aug 26, 2022 Myriad Genetics Gets Expanded Coverage for BRACAnalysis CDx in Japan Aug 12, 2022 Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer Jul 15, 2022 Almac, AstraZeneca CDx Partnership Branching Out to New Disease Areas, Drawing on NGS, qPCR Premium Jun 22, 2022 Biocartis, AstraZeneca Ink Companion Diagnostic Pact Jun 20, 2022 Chinese Nanopore Sequencing Tech Firm Axbio Raises $100M in Series B Financing Jun 2, 2022 Grail, AstraZeneca Partner on Companion Dx for Oncology Drugs Mar 11, 2022 FDA Approves Lynparza as Adjuvant Therapy With Myriad Genetics CDx for BRCA-Mutated Breast Cancer Feb 24, 2022 Sophia Genetics, AstraZeneca Team on In-House HRD Testing in Ovarian Cancer Nov 2, 2021 Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal Oct 25, 2021 UK Biobank WGS Consortium Describes 150K Genome Dataset at ASHG, Sets Sights on 500K Premium Sep 20, 2021 Genomenon, Alexion Pharmaceuticals Team on Rare Disease Dx Sep 1, 2021 Thermo Fisher Scientific, AstraZeneca Team up to Develop CDx for Targeted Drugs Sep 1, 2021 New Research Consortium to Standardize Single-Cell Sequencing for Cancer Drug Resistance Studies Jun 14, 2021 Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer Jun 7, 2021 Lynparza Benefit in Early BRCA-Mutated Breast Cancer Reignites Universal Genetic Testing Discussion Premium Jun 4, 2021 Akoya Biosciences, AstraZeneca Collaborate on Spatial Biomarker Profiling for Immuno-Oncology Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.